The decimation of reefs from stony coral tissue loss disease prompted the use of a topical amoxicillin treatment to prevent coral mortality. Application of this treatment led to concerns about unintentional impacts such as potential alteration of the coral microbiome and possible spread of antibiotic resistance. We used three different methodologies—microbial RNA sequencing, 16S rRNA amplicon surveys, and microbial qPCR array—to assess these concerns and to establish a baseline of antibiotic resistance genes (ARGs) in untreated coral microbes. We conducted microbial RNA sequencing on wild Montastraea cavernosa coral mucus samples collected before and 24 h after amoxicillin application. While diverse antibiotic resistance genes (ARGs) were expressed, no differences in ARG expression were detected after amoxicillin treatment. Additionally, there were no notable changes in the microbial communities between the before and after samples. In a separate experiment, a microbial qPCR array was used to assess differences in ARGs over longer timescales using cores from wild Colpophyllia natans, comparing never-treated corals with ones treated a single time seven months prior and with those treated multiple times seven months and more prior. No clinically relevant ARGs were detected across any samples. A small number of above-detection reads (4 in the never-treated corals, 2 in the once-treated corals, and 0 in the multi-treated corals) may indicate weak amplification of similar environmental (non-anthropogenic) ARGs in the corals. Results indicate that the localized topical application of amoxicillin to prevent mortality of SCTLD-affected corals does not: (1) significantly disrupt microbiomes, (2) increase ARG expression in adjacent tissues of these species within 24 h, nor (3) increase abundance of clinically relevant ARGs over a 7 month time period.